SCHEMBL1991148

SCHEMBL1991148

CCOC(=O)C1(C)COc2ccccc2C1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
GLA P06280 3/20 0.47
MAPT P10636 3/20 0.47
CTDSP1 Q9GZU7 2/20 0.44
GRM1 Q13255 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
CYP2C19 P33261 1/20 0.44
RECQL P46063 1/20 0.44
ATM Q13315 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
BRD4 O60885 1/20 0.40
IDO1 P14902 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3517906 0.80 PKM (0.41) ALDH1A1MAPTKDM4ECYP3A4CYP2C9
SCHEMBL19838777 0.76 BRD4 (0.52) ALDH1A1GLAMAPTKDM4ECYP1A2
SCHEMBL29596532 0.76 BRD4 (0.52) ALDH1A1GLAMAPTKDM4ECYP1A2
SCHEMBL10507693 0.73 ALDH1A1 (0.53) ALDH1A1GLAMAPTCTDSP1GRM1
SCHEMBL10381743 0.73 ALDH1A1 (0.43) ALDH1A1GLAMAPTCTDSP1GRM1
SCHEMBL3611955 0.72 ATM (0.36) ALDH1A1GLAMAPTCTDSP1GRM1
SCHEMBL2156979 0.71 PRKCA (0.44) ALDH1A1GLAMAPTKDM4ECYP3A4
SCHEMBL1984035 0.71 BRD4 (0.56) ALDH1A1GLAMAPTCTDSP1GRM1
SCHEMBL12737809 0.71 ALDH1A1 (0.42) ALDH1A1GLAMAPTCTDSP1GRM1
SCHEMBL29448029 0.71 PKM (0.47) ALDH1A1MAPTCYP3A4CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110150833-A1 BENZOPYRANS AND ANALOGS AS RHO KINASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2011-06-23 US disclosed
EP-2234618-A1 BENZOPYRANS AND ANALOGS AS RHO KINASE INHIBITORS The Scripps Research Institute (US) 2010-10-06 EP disclosed
US-7667053-B2 Cannabinoid-1 (CB1) receptor antagonists and/or inverse agonists; e.g. N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1,4-benzodioxane-2-carboxamide; psychological disorders, eating disorders MERCK & CO., INC. (US) 2010-02-23 US disclosed
WO-2009079008-A1 BENZOPYRANS AND ANALOGS AS RHO KINASE INHIBITORS FENG YANGBO (US) 2009-06-25 WO disclosed
EP-1499306-A4 BICYCLIC AMIDES MERCK & CO INC (US) 2007-03-28 EP disclosed
US-20050203112-A1 Bicyclic amides MERCK SHARP & DOHME CORP. 2005-09-15 US disclosed
EP-1499306-A2 BICYCLIC AMIDES Merck & Co., Inc. (US) 2005-01-26 EP disclosed
WO-2003086288-A2 BICYCLIC AMIDES MERCK & CO., INC. (US) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203112-A1 Bicyclic amides CNR1, CNR2, FAAH ALDH1A1 3047/4885GLA 1283/4885MAPT 1054/4885
US-20110150833-A1 BENZOPYRANS AND ANALOGS AS RHO KINASE INHIBITORS ROCK1, RHOA, RHOT2 ALDH1A1 1516/4885GLA 1520/4885MAPT 3442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.